1. Clinical features and therapy of 'typical' and 'atypical' bronchial carcinoid tumors (grade 1 and grade 2 neuroendocrine carcinoma)
- Author
-
G. Friehs, Helmut Popper, Freyja-Maria Smolle-Jüttner, Pinter H, H. Klemen, Josef Smolle, and M. Pongratz-Roeger
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Pathology ,Lung Neoplasms ,Adolescent ,Bronchial carcinoid ,Gastroenterology ,Cohort Studies ,Internal medicine ,Epidemiology ,medicine ,Humans ,Survival rate ,Aged ,Neoplasm Staging ,Analysis of Variance ,Chi-Square Distribution ,business.industry ,Incidence (epidemiology) ,Respiratory disease ,General Medicine ,Middle Aged ,medicine.disease ,Prognosis ,Carcinoma, Adenoid Cystic ,Survival Rate ,Carcinoma, Bronchogenic ,Lymphatic Metastasis ,Multivariate Analysis ,Surgery ,Female ,Analysis of variance ,Cardiology and Cardiovascular Medicine ,business ,Chi-squared distribution ,Cohort study - Abstract
Between 1971 and 1992, 55 patients with grade 1 (G1) (n = 32) or grade 2 (G2) (n = 23) neuroendocrine bronchial carcinomas (males: 26, females: 29; mean age: 47.7 years, range: 13-77 years) were treated. The sexes were evenly distributed in the two groups. Patients with G1 were significantly younger than those with G2 tumors (43.3 vs 53.7 years; P0.05). There were no statistically significant differences between G1 and G2 concerning peripheral or central localization, laterality or maximum tumor diameters. Patients with G1 had a higher incidence of tumor-related symptoms and a longer mean duration of these symptoms (21.8 months) than G2 cases (14 months) but the differences were not statistically significant either. No case displayed any symptoms of hormonal activity. Fifty-two patients underwent resection, one was non-resectable for anatomical, and one for functional, reasons; a third refused an operation. We performed 8 pneumonectomies, 36 lobectomies (8 by using bronchoplasty), 2 bronchotomies and 6 segmental resections. Twelve G2 cases had N1 or N2 lymph node metastases, two intrapulmonary metastases were removed. After a median observation time of 55.7 months the 10-year survival rate for the total collective is 90.6%. For G1 it is 100%, compared with 76.4% for G2 patients, 3 of whom died of the tumor (P0.05; significant). In univariate analysis: age over 48 years, lymphatic invasion, and lymph node metastasis were also significantly correlated with a poor survival rate. Multivariate analysis proved lymphatic permeation to be the only independent prognostic factor (the survival rate was 100% where there was no invasion, but only 74% where this had occurred).
- Published
- 1993